| Recruiting | Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy NCT07222800 | Pfizer | Phase 3 |
| Not Yet Recruiting | IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx NCT07196540 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the NCT06794073 | Shanghai Zhongshan Hospital | N/A |
| Recruiting | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal C NCT06365866 | Taipei Veterans General Hospital, Taiwan | N/A |
| Recruiting | Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery NCT07404527 | Institute of Oncology Ljubljana | N/A |
| Recruiting | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatm NCT06026800 | Sir Run Run Shaw Hospital | Phase 1 |
| Recruiting | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive Syst NCT06019702 | Sir Run Run Shaw Hospital | Phase 1 |
| Recruiting | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neo NCT06026774 | Sir Run Run Shaw Hospital | Phase 1 |
| Recruiting | Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. NCT05624099 | Fujian Cancer Hospital | Phase 2 |
| Unknown | Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma NCT05913661 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Unknown | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery NCT04962958 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Recruiting | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patient NCT05252078 | Jiangxi Provincial Cancer Hospital | Phase 2 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Diges NCT05287165 | Beijing Immunochina Medical Science & Technology Co., Ltd. | EARLY_Phase 1 |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282 | Sociedad Española de Medicina Nuclear e Imagen Molecular | — |
| Unknown | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Un NCT05322486 | State Scientific Centre of Coloproctology, Russian Federation | — |
| Completed | Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under NCT04556344 | University Hospital, Lille | N/A |
| Active Not Recruiting | Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gas NCT05602935 | The Second Affiliated Hospital of Fujian Medical University | Phase 2 |
| Completed | TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC NCT04518852 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Completed | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients NCT04080843 | Zhejiang University | Phase 2 |
| Unknown | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms NCT04755543 | Taizhou HoudeAoke Biomedical Co., Ltd. | Phase 1 |
| Unknown | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer NCT03889626 | Fudan University | Phase 3 |
| Completed | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma NCT03717298 | Catalysis SL | Phase 2 |
| Unknown | Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) NCT03271255 | Shenzhen People's Hospital | Phase 2 |
| Terminated | Observatory of the Quality of Surgical Procedures for Digestive Cancers NCT03681600 | Moroccan Society of Surgery | — |
| Terminated | Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonar NCT03306693 | University Hospital, Lille | N/A |
| Unknown | Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) NCT03488446 | Nanfang Hospital, Southern Medical University | — |
| Completed | Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients NCT03117348 | Jinling Hospital, China | N/A |
| Completed | Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients NCT03115957 | Jinling Hospital, China | N/A |
| Completed | BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities NCT03072472 | South Tyneside and Sunderland NHS Foundation Trust | N/A |
| Completed | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors NCT02909452 | Syndax Pharmaceuticals | Phase 1 |
| Completed | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors NCT02897778 | Syndax Pharmaceuticals | Phase 1 |
| Recruiting | EUS-guided RFA for Solid Abdominal Neoplasms NCT03221335 | Chinese University of Hong Kong | N/A |
| Unknown | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer NCT02644863 | Shenzhen Hornetcorn Bio-technology Company, LTD | Phase 2 |
| Unknown | DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma NCT02487017 | Shenzhen Hornetcorn Bio-technology Company, LTD | Phase 2 |
| Unknown | Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization NCT02208804 | UMC Utrecht | Phase 2 / Phase 3 |
| Unknown | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer NCT02215837 | Shenzhen Hornetcorn Bio-technology Company, LTD | Phase 2 |
| Unknown | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cance NCT02202928 | Shenzhen Hornetcorn Bio-technology Company, LTD | Phase 2 |
| Completed | Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestiv NCT02781532 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic NCT01964430 | Celgene | Phase 3 |
| Unknown | Celiac Plexus Radiosurgery for Pain Management NCT02356406 | Sheba Medical Center | Phase 2 |
| Completed | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC NCT01996306 | Epidemiological and Clinical Research Information Network | Phase 3 |
| Unknown | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous In NCT01995942 | Royal Marsden NHS Foundation Trust | — |
| Unknown | Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients NCT01786122 | Basque Health Service | N/A |
| Completed | 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients NCT01832116 | University Medical Center Groningen | Phase 1 |
| Unknown | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate He NCT01556815 | Shandong Cancer Hospital and Institute | Phase 2 |
| Unknown | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC NCT03303495 | Sun Yat-sen University | Phase 3 |
| Terminated | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) NCT01009593 | Abbott | Phase 3 |
| Unknown | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks NCT01037049 | Royal Marsden NHS Foundation Trust | Phase 2 |
| Unknown | Low Rectal Cancer Study (MERCURY II) NCT02005965 | Royal Marsden NHS Foundation Trust | — |
| Completed | Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Me NCT00392366 | BioTex, Inc. | N/A |